期刊
CLINICAL INFECTIOUS DISEASES
卷 50, 期 11, 页码 1493-1496出版社
OXFORD UNIV PRESS INC
DOI: 10.1086/652655
关键词
-
资金
- Southeast Regional Center of Excellence for Emerging Infections and Biodefense
- National Institute of Allergy and Infectious Diseases [U54 AI57157]
Immunosuppressed patients receiving oseltamivir for 2009 novel H1N1 influenza A infection may develop drug resistance, leading to treatment failure. Intravenous zanamivir was administered on a compassionate-use basis to a profoundly immunosuppressed pediatric patient with severe oseltamivir-resistant novel H1N1 pneumonia. The regimen was well tolerated and was associated with a decrease in viral burden.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据